Satavaptan treatment for ascites in patients with cirrhosis: a meta-analysis of effect on hepatic encephalopathy development.
about
Epilepsy as a risk factor for hepatic encephalopathy in patients with cirrhosis: a cohort study.Revealing the Effects of the Herbal Pair of Euphorbia kansui and Glycyrrhiza on Hepatocellular Carcinoma Ascites with Integrating Network Target Analysis and Experimental ValidationEffect of Glycyrrhiza on the Diuretic Function of Euphorbia kansui: An Ascites Mouse ModelTherapeutic effects of Euphorbia Pekinensis and Glycyrrhiza glabra on Hepatocellular Carcinoma Ascites Partially Via Regulating the Frk-Arhgdib-Inpp5d-Avpr2-Aqp4 Signal Axis.Electrolyte and Acid-Base Disturbances in End-Stage Liver Disease: A Physiopathological Approach.Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites.Hyponatraemia and cirrhosis.The burden of minimal hepatic encephalopathy: from diagnosis to therapeutic strategies.Benzodiazepines and risk for hepatic encephalopathy in patients with cirrhosis and ascites.Correction of Hyponatremia May Be a Treatment Stratification Biomarker: A Two-Stage Systematic Review and Meta-Analysis
P2860
Q36085443-D8551424-28E8-48A2-A4AB-AC415031B0BCQ36855036-0AD123F5-99F7-4EB1-AA46-870688572E22Q36924811-404F54DF-5029-41A7-B4D1-C496160DE0E3Q37626077-488504C0-50D9-4566-A5E5-C005F99494EDQ39304722-9A421524-026F-4DC1-9F5C-D4A63807F96EQ39542998-C516C87A-9CA1-4711-A5E6-B7F8C0220B08Q41946824-6372E09B-E7D7-4C31-885B-E41F58C4CFFBQ50532497-33B9DCB4-9125-4644-8B62-6DFE8E92439AQ54960926-21DDF9BE-588F-45E7-B08D-7A9B93118248Q58758423-DA7DF78A-3AC5-44E5-AD3D-8F4D7DE341DE
P2860
Satavaptan treatment for ascites in patients with cirrhosis: a meta-analysis of effect on hepatic encephalopathy development.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Satavaptan treatment for ascit ...... ic encephalopathy development.
@en
type
label
Satavaptan treatment for ascit ...... ic encephalopathy development.
@en
prefLabel
Satavaptan treatment for ascit ...... ic encephalopathy development.
@en
P2093
P2860
P1476
Satavaptan treatment for ascit ...... tic encephalopathy development
@en
P2093
Florence Wong
Hendrik Vilstrup
Hugh Watson
Juan Córdoba
P2860
P2888
P304
P356
10.1007/S11011-013-9384-4
P577
2013-03-06T00:00:00Z
P5875
P6179
1004207593